StockData
Aquestive Therapeutics, Inc. logo

Aquestive Therapeutics, Inc. (AQST) stock

AQSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 3/30
$3.78+0.08 (+2.16%)

Close on Nov 18, 2026Market cap $474.43MP/E –Yield –

Aquestive Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Aquestive Therapeutics's market cap was $449.33M on Nov 11, 2026, against $753.06M a year earlier. Over the last 5 years it ranged from $26.63M to $785.91M, with a median of $260.58M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$449.33M-42.8%
2025Dec 31, 2025$785.91M+142.1%
2024Dec 31, 2024$324.59M+140.8%
2023Dec 29, 2023$134.82M+177.5%
2022Dec 30, 2022$48.58M-68.8%
2021Dec 31, 2021$155.92M-13.3%
2020Dec 31, 2020$179.87M+23.4%
2019Dec 31, 2019$145.75M-7.2%
2018Dec 31, 2018$157.14M–

More Aquestive Therapeutics figures

See a number that looks wrong?